Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1996 May 15;24(10):1873–1878. doi: 10.1093/nar/24.10.1873

Structural and functional analysis of the human Y-box binding protein (YB-1) gene promoter.

Y Makino 1, T Ohga 1, S Toh 1, K Koike 1, K Okumura 1, M Wada 1, M Kuwano 1, K Kohno 1
PMCID: PMC145870  PMID: 8657568

Abstract

We have isolated three overlapping genomic clones containing the 5'portion of the human YB-1 gene. These clones span approximately 25 kb of contiguous DNA containing 10 kb of 5' flanking sequence and 15 kb of the gene. The nucleotide sequence of the first exon and of 2000 upstream base pairs (bp) was determined. The first axon is unusually large and contains a 166 bp coding sequence and a 331 bp untranslated region. CpG sequences cover the 5'-end of the YB-1 gene including its first axon and intron as well as the upstream regions. The GC content around the first exon is approximately 70% and a CpG-free region was located in the untranslated sequence. The segment preceding the major transcription initiation site does not contain a TATA box, CCAAT box and the binding sequence for known transcription factors. A transient expression assay using the chloramphenicol acetyltransferase (CAT) gene showed that the sequence from +24 to +281 was critical for CAT expression. Fluorescence in situ hybridization demonstrated the chromosomal locus of YB-1 gene on chromosome 1p34. Polymerase chain reaction analysis on other genomic phage DNAs showed that several clones were derived from pseudogenes.

Full Text

The Full Text of this article is available as a PDF (141.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asakuno K., Kohno K., Uchiumi T., Kubo T., Sato S., Isono M., Kuwano M. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. Biochem Biophys Res Commun. 1994 Mar 30;199(3):1428–1435. doi: 10.1006/bbrc.1994.1390. [DOI] [PubMed] [Google Scholar]
  2. Borst P., Schinkel A. H., Smit J. J., Wagenaar E., Van Deemter L., Smith A. J., Eijdems E. W., Baas F., Zaman G. J. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther. 1993 Nov;60(2):289–299. doi: 10.1016/0163-7258(93)90011-2. [DOI] [PubMed] [Google Scholar]
  3. Didier D. K., Schiffenbauer J., Woulfe S. L., Zacheis M., Schwartz B. D. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7322–7326. doi: 10.1073/pnas.85.19.7322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldsmith M. E., Madden M. J., Morrow C. S., Cowan K. H. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J Biol Chem. 1993 Mar 15;268(8):5856–5860. [PubMed] [Google Scholar]
  5. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Herbomel P., Bourachot B., Yaniv M. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell. 1984 Dec;39(3 Pt 2):653–662. doi: 10.1016/0092-8674(84)90472-0. [DOI] [PubMed] [Google Scholar]
  7. Kohno K., Sato S., Takano H., Matsuo K., Kuwano M. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1415–1421. doi: 10.1016/0006-291x(89)92761-7. [DOI] [PubMed] [Google Scholar]
  8. Kohno K., Sato S., Uchiumi T., Takano H., Kato S., Kuwano M. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem. 1990 Nov 15;265(32):19690–19696. [PubMed] [Google Scholar]
  9. Kohno K., Sullivan M., Yamada Y. Structure of the promoter of the rat type II procollagen gene. J Biol Chem. 1985 Apr 10;260(7):4441–4447. [PubMed] [Google Scholar]
  10. Kohno K., Tanimura H., Sato S., Nakayama Y., Makino Y., Wada M., Fojo A. T., Kuwano M. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J Biol Chem. 1994 Aug 12;269(32):20503–20508. [PubMed] [Google Scholar]
  11. Kudo S., Mattei M. G., Fukuda M. Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold-shock domain. Eur J Biochem. 1995 Jul 1;231(1):72–82. doi: 10.1111/j.1432-1033.1995.tb20672.x. [DOI] [PubMed] [Google Scholar]
  12. Kusaba H., Kohno K., Asakuno K., Kuwano M., Okumura K., Green E. D., Schlessinger D., Wada M. Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells. Genome Res. 1995 Oct;5(3):245–258. doi: 10.1101/gr.5.3.245. [DOI] [PubMed] [Google Scholar]
  13. Ladomery M., Sommerville J. A role for Y-box proteins in cell proliferation. Bioessays. 1995 Jan;17(1):9–11. doi: 10.1002/bies.950170104. [DOI] [PubMed] [Google Scholar]
  14. Lichter P., Cremer T., Borden J., Manuelidis L., Ward D. C. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum Genet. 1988 Nov;80(3):224–234. doi: 10.1007/BF01790090. [DOI] [PubMed] [Google Scholar]
  15. Miyazaki M., Kohno K., Uchiumi T., Tanimura H., Matsuo K., Nasu M., Kuwano M. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem Biophys Res Commun. 1992 Sep 16;187(2):677–684. doi: 10.1016/0006-291x(92)91248-o. [DOI] [PubMed] [Google Scholar]
  16. Ponce M. R., Micol J. L. PCR amplification of long DNA fragments. Nucleic Acids Res. 1992 Feb 11;20(3):623–623. doi: 10.1093/nar/20.3.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Takahashi E., Hori T., O'Connell P., Leppert M., White R. R-banding and nonisotopic in situ hybridization: precise localization of the human type II collagen gene (COL2A1). Hum Genet. 1990 Nov;86(1):14–16. doi: 10.1007/BF00205165. [DOI] [PubMed] [Google Scholar]
  18. Takahashi E., Yamauchi M., Tsuji H., Hitomi A., Meuth M., Hori T. Chromosome mapping of the human cytidine-5'-triphosphate synthetase (CTPS) gene to band 1p34.1-p34.3 by fluorescence in situ hybridization. Hum Genet. 1991 Nov;88(1):119–121. doi: 10.1007/BF00204942. [DOI] [PubMed] [Google Scholar]
  19. Tanimura H., Kohno K., Sato S., Uchiumi T., Miyazaki M., Kobayashi M., Kuwano M. The human multidrug resistance 1 promoter has an element that responds to serum starvation. Biochem Biophys Res Commun. 1992 Mar 16;183(2):917–924. doi: 10.1016/0006-291x(92)90571-2. [DOI] [PubMed] [Google Scholar]
  20. Torigoe K., Sato S., Kusaba H., Kohno K., Kuwano M., Okumura K., Green E. D., Tsui L. C., Scherer S. W., Schlessinger D. A YAC-based contig of 1.5 Mb spanning the human multidrug resistance gene region and delineating the amplification unit in three human multidrug-resistant cell lines. Genome Res. 1995 Oct;5(3):233–244. doi: 10.1101/gr.5.3.233. [DOI] [PubMed] [Google Scholar]
  21. Uchiumi T., Kohno K., Tanimura H., Matsuo K., Sato S., Uchida Y., Kuwano M. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ. 1993 Mar;4(3):147–157. [PubMed] [Google Scholar]
  22. Wolffe A. P. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays. 1994 Apr;16(4):245–251. doi: 10.1002/bies.950160407. [DOI] [PubMed] [Google Scholar]
  23. Yokomizo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., Okamoto T., Yodoi J., Kuwano M., Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 1995 Oct 1;55(19):4293–4296. [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES